News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
674,683 Results
Type
Article (38613)
Company Profile (192)
Press Release (635878)
Section
Business (202885)
Career Advice (1957)
Deals (35340)
Drug Delivery (74)
Drug Development (80463)
Employer Resources (167)
FDA (15929)
Job Trends (14754)
News (342747)
Policy (32379)
Tag
Academia (2532)
Africa (708)
Allergies (37)
Alliances (48877)
Alzheimer's disease (1093)
Antibody-drug conjugate (ADC) (43)
Approvals (15872)
Arizona (159)
Artificial intelligence (48)
Asia (36592)
Australia (5950)
Bankruptcy (350)
Best Places to Work (11173)
Biosimilars (55)
C2C Services and Suppliers (78811)
California (820)
Canada (641)
Cancer (176)
Career advice (1635)
CAR-T (32)
Cell therapy (65)
China (48)
Clinical research (62591)
Collaboration (56)
Colorado (33)
Compensation (30)
COVID-19 (2452)
Cystic fibrosis (69)
Diabetes (32)
Diagnostics (5889)
Diversity, equity & inclusion (44)
Drug pricing (47)
Earnings (82758)
Employer resources (141)
Europe (78145)
Events (106924)
FDA (15973)
Florida (106)
Funding (37)
Gene therapy (52)
GLP-1 (465)
Government (4272)
Healthcare (18527)
Hotbed/Location (481084)
Idaho (55)
Illinois (194)
Indiana (105)
Infectious disease (2465)
Inflammatory bowel disease (83)
Interviews (305)
IPO (16116)
Job creations (3617)
Job search strategy (1410)
Kansas (90)
Layoffs (373)
Legal (7814)
Liver cancer (51)
Lung cancer (37)
Maine (47)
Management (53)
Manufacturing (45)
Maryland (251)
Massachusetts (450)
Medical device (12944)
Medtech (12947)
Mergers & acquisitions (18925)
Metabolic disorders (154)
Neuroscience (1170)
New Jersey (62)
New York (83)
NextGen Class of 2024 (6447)
Non-profit (4442)
North Carolina (158)
Obesity (101)
Opinion (160)
Parkinson's disease (29)
Patents (33)
Peanut (33)
Pennsylvania (55)
People (55529)
Phase I (19399)
Phase II (27570)
Phase III (20617)
Policy (33)
Postmarket research (2544)
Preclinical (8270)
Rare diseases (89)
Real estate (5881)
Recruiting (63)
Regulatory (21012)
Reports (32)
Research institute (2300)
Resumes & cover letters (343)
South America (1085)
Startups (3552)
Texas (87)
United States (3002)
Vaccines (408)
Washington State (113)
Weight loss (96)
Date
Today (63)
Last 7 days (496)
Last 30 days (1912)
Last 365 days (38267)
2024 (21600)
2023 (40081)
2022 (51181)
2021 (55722)
2020 (54105)
2019 (46556)
2018 (35034)
2017 (32126)
2016 (31489)
2015 (37570)
2014 (31334)
2013 (26362)
2012 (28576)
2011 (29266)
2010 (27335)
674,683 Results for "triana biomedicines inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
TRIANA Biomedicines to Present at UBS Biotechnology Private Company Virtual Symposium
TRIANA Biomedicines, Inc. today announced that Dr. Patrick Trojer, President and Chief Executive Officer, will present at the UBS Biotechnology Private Company Virtual Symposium on Wednesday September 20, 2023 at 3:30 PM ET.
September 18, 2023
·
1 min read
Business
TRIANA Biomedicines Announces the Appointments of Vito Palombella as Chief Scientific Officer and Reza Mazhari as Chief Business Officer
TRIANA Biomedicines, Inc. today announced the appointments of Dr. Vito Palombel as Chief Scientific Officer and Dr. Reza Mazhari as Chief Business Officer.
September 12, 2023
·
5 min read
Biotech Bay
Innovent Provides Interpretation and Updates on Clinical Data from Mazdutide GLORY-1 Study and General Biomedicine Pipeline
Innovent Biologics, Inc. provided interpretation and updates on clinical data from Mazdutide’s GLORY-1 study and its general biomedicine pipeline at an investor conference call on June 25.
June 27, 2024
·
9 min read
Genetown
TRIANA Biomedicines Announces Participation in Upcoming Investor Conference
TRIANA Biomedicines, Inc. today announced that Dr. Patrick Trojer, President and Chief Executive Officer, will present at UBS Virtual Biotechnology Private Company Symposium on Thursday September 22, 2022 at 4:00 PM ET.
September 19, 2022
·
1 min read
Biotech Beach
Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines
Endeavor BioMedicines, Inc. today announced the closing of a $132.5 million Series C financing, including the conversion of a $5 million convertible instrument.
April 24, 2024
·
4 min read
Business
Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board
Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Wendy Chung, M.D., Ph.D., has joined Sail’s Board of Directors.
April 2, 2024
·
2 min read
Genetown
TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board
TRIANA Biomedicines, Inc. announced the addition of Robert A. Copeland, PhD, and Adrian M. Senderowicz, MD to its Scientific Advisory Board.
June 23, 2022
·
4 min read
Business
Endeavor BioMedicines Announces Appointment of Chris Krueger, J.D., as Chief Operating Officer
Endeavor BioMedicines today announced the appointment of Chris Krueger, J.D., as Chief Operating Officer (COO). Mr. Krueger brings extensive experience from the life sciences industry that will be instrumental to Endeavor’s continued growth and success.
April 16, 2024
·
2 min read
Business
Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. as President and Vishaal Turakhia as Chief Financial Officer
Endeavor BioMedicines today announced the appointment of Enoch Kariuki, Pharm.D. as President and Vishaal Turakhia as Chief Financial Officer (CFO).
March 14, 2024
·
3 min read
Business
Sail Biomedicines Appoints Kerry Benenato, Ph.D., as Chief Platform Officer
Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Kerry Benenato, Ph.D., has been appointed to the position of the role of Chief Platform Officer, replacing Stuart Milstein, Ph.D., who is leaving the company to pursue other opportunities.
February 7, 2024
·
3 min read
1 of 67,469
Next
